US Stock MarketDetailed Quotes

TOVX Theriva Biologics

Watchlist
  • 1.2400
  • -0.0400-3.13%
Close Oct 2 16:00 ET
  • 1.2600
  • +0.0200+1.61%
Post 16:52 ET
2.82MMarket Cap-39P/E (TTM)

Theriva Biologics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-24.05%4.42M
4.13%5.39M
-0.70%21.43M
-15.03%6.22M
-15.40%4.22M
15.80%5.82M
21.78%5.18M
51.19%21.58M
38.97%7.32M
52.24%4.99M
Selling and administrative expenses
-45.40%1.47M
-12.18%1.93M
-27.77%7.12M
-52.40%2.02M
-91.23%212K
74.37%2.69M
32.99%2.2M
52.27%9.86M
70.80%4.25M
85.42%2.42M
-General and administrative expense
-45.40%1.47M
-12.18%1.93M
-27.77%7.12M
-52.40%2.02M
-91.23%212K
74.37%2.69M
32.99%2.2M
52.27%9.86M
70.80%4.25M
85.42%2.42M
Research and development costs
-5.75%2.95M
16.19%3.46M
22.08%14.31M
36.63%4.2M
55.88%4.01M
-10.10%3.13M
14.63%2.98M
50.29%11.72M
10.51%3.07M
30.32%2.57M
Operating profit
24.05%-4.42M
-4.13%-5.39M
0.70%-21.43M
15.03%-6.22M
15.40%-4.22M
-15.80%-5.82M
-21.78%-5.18M
-51.19%-21.58M
-38.97%-7.32M
-52.24%-4.99M
Net non-operating interest income expense
-54.59%173K
-37.36%228K
181.05%1.44M
-0.95%312K
124.71%382K
1,365.38%381K
18,100.00%364K
8,433.33%512K
15,650.00%315K
8,400.00%170K
Non-operating interest income
-54.59%173K
-37.36%228K
181.05%1.44M
-0.95%312K
124.71%382K
1,365.38%381K
18,100.00%364K
8,433.33%512K
15,650.00%315K
8,400.00%170K
Other net income (expense)
-101,625.00%-4.07M
-116.67%-1K
107.32%3K
-300.00%-4K
166.67%6K
55.56%-4K
126.09%6K
-41K
-1K
-9K
Gain on sale of security
75.00%-1K
-116.67%-1K
107.32%3K
-300.00%-4K
166.67%6K
55.56%-4K
126.09%6K
---41K
---1K
---9K
Special income (charges)
---4.07M
----
----
----
----
--0
----
----
----
----
-Less:Impairment of capital assets
--4.07M
----
----
----
----
--0
----
----
----
----
Income before tax
-52.78%-8.32M
-7.43%-5.17M
5.31%-19.99M
15.62%-5.91M
20.62%-3.83M
-8.66%-5.44M
-12.52%-4.81M
-47.95%-21.11M
-33.06%-7M
-47.42%-4.83M
Income tax
0
0
-15.09%-1.64M
24.01%-424K
-57.31%-527K
32.52%-359K
-330K
-1.43M
-558K
-335K
Net income
-63.57%-8.32M
-15.34%-5.17M
6.79%-18.35M
14.90%-5.49M
26.44%-3.3M
-13.56%-5.08M
-4.80%-4.48M
-37.97%-19.69M
-22.46%-6.45M
-37.18%-4.49M
Net income continuous Operations
-63.57%-8.32M
-15.34%-5.17M
6.79%-18.35M
14.90%-5.49M
26.44%-3.3M
-13.56%-5.08M
-4.80%-4.48M
-37.97%-19.69M
-22.46%-6.45M
-37.18%-4.49M
Minority interest income
Net income attributable to the parent company
-63.57%-8.32M
-15.34%-5.17M
6.79%-18.35M
14.90%-5.49M
26.44%-3.3M
-13.56%-5.08M
-4.80%-4.48M
-37.98%-19.69M
-22.46%-6.45M
-37.18%-4.49M
Preferred stock dividends
Other preferred stock dividends
0
0
0
-95.41%340K
0
340K
Net income attributable to common stockholders
-63.57%-8.32M
-15.34%-5.17M
8.37%-18.35M
14.90%-5.49M
31.61%-3.3M
-13.56%-5.08M
-4.80%-4.48M
13.64%-20.03M
-22.46%-6.45M
-47.57%-4.83M
Basic earnings per share
-26.47%-10.75
0.00%-7.5
12.98%-28.5
25.00%-8.25
36.67%-4.75
-21.43%-8.5
3.23%-7.5
31.05%-32.75
-12.82%-11
-20.00%-7.5
Diluted earnings per share
-26.47%-10.75
0.00%-7.5
12.98%-28.5
25.00%-8.25
36.67%-4.75
-21.43%-8.5
3.23%-7.5
31.05%-32.75
-12.82%-11
-20.00%-7.5
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -24.05%4.42M4.13%5.39M-0.70%21.43M-15.03%6.22M-15.40%4.22M15.80%5.82M21.78%5.18M51.19%21.58M38.97%7.32M52.24%4.99M
Selling and administrative expenses -45.40%1.47M-12.18%1.93M-27.77%7.12M-52.40%2.02M-91.23%212K74.37%2.69M32.99%2.2M52.27%9.86M70.80%4.25M85.42%2.42M
-General and administrative expense -45.40%1.47M-12.18%1.93M-27.77%7.12M-52.40%2.02M-91.23%212K74.37%2.69M32.99%2.2M52.27%9.86M70.80%4.25M85.42%2.42M
Research and development costs -5.75%2.95M16.19%3.46M22.08%14.31M36.63%4.2M55.88%4.01M-10.10%3.13M14.63%2.98M50.29%11.72M10.51%3.07M30.32%2.57M
Operating profit 24.05%-4.42M-4.13%-5.39M0.70%-21.43M15.03%-6.22M15.40%-4.22M-15.80%-5.82M-21.78%-5.18M-51.19%-21.58M-38.97%-7.32M-52.24%-4.99M
Net non-operating interest income expense -54.59%173K-37.36%228K181.05%1.44M-0.95%312K124.71%382K1,365.38%381K18,100.00%364K8,433.33%512K15,650.00%315K8,400.00%170K
Non-operating interest income -54.59%173K-37.36%228K181.05%1.44M-0.95%312K124.71%382K1,365.38%381K18,100.00%364K8,433.33%512K15,650.00%315K8,400.00%170K
Other net income (expense) -101,625.00%-4.07M-116.67%-1K107.32%3K-300.00%-4K166.67%6K55.56%-4K126.09%6K-41K-1K-9K
Gain on sale of security 75.00%-1K-116.67%-1K107.32%3K-300.00%-4K166.67%6K55.56%-4K126.09%6K---41K---1K---9K
Special income (charges) ---4.07M------------------0----------------
-Less:Impairment of capital assets --4.07M------------------0----------------
Income before tax -52.78%-8.32M-7.43%-5.17M5.31%-19.99M15.62%-5.91M20.62%-3.83M-8.66%-5.44M-12.52%-4.81M-47.95%-21.11M-33.06%-7M-47.42%-4.83M
Income tax 00-15.09%-1.64M24.01%-424K-57.31%-527K32.52%-359K-330K-1.43M-558K-335K
Net income -63.57%-8.32M-15.34%-5.17M6.79%-18.35M14.90%-5.49M26.44%-3.3M-13.56%-5.08M-4.80%-4.48M-37.97%-19.69M-22.46%-6.45M-37.18%-4.49M
Net income continuous Operations -63.57%-8.32M-15.34%-5.17M6.79%-18.35M14.90%-5.49M26.44%-3.3M-13.56%-5.08M-4.80%-4.48M-37.97%-19.69M-22.46%-6.45M-37.18%-4.49M
Minority interest income
Net income attributable to the parent company -63.57%-8.32M-15.34%-5.17M6.79%-18.35M14.90%-5.49M26.44%-3.3M-13.56%-5.08M-4.80%-4.48M-37.98%-19.69M-22.46%-6.45M-37.18%-4.49M
Preferred stock dividends
Other preferred stock dividends 000-95.41%340K0340K
Net income attributable to common stockholders -63.57%-8.32M-15.34%-5.17M8.37%-18.35M14.90%-5.49M31.61%-3.3M-13.56%-5.08M-4.80%-4.48M13.64%-20.03M-22.46%-6.45M-47.57%-4.83M
Basic earnings per share -26.47%-10.750.00%-7.512.98%-28.525.00%-8.2536.67%-4.75-21.43%-8.53.23%-7.531.05%-32.75-12.82%-11-20.00%-7.5
Diluted earnings per share -26.47%-10.750.00%-7.512.98%-28.525.00%-8.2536.67%-4.75-21.43%-8.53.23%-7.531.05%-32.75-12.82%-11-20.00%-7.5
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data